Skip to content

News

ASCO News: Weekly Chemo Improves Quality of Life

ASCO News: Weekly Chemo Improves Quality of Life

In research presented at the American Society of Clinical Oncology meeting this week, researchers found that shortening the break between chemotherapy sessions improved quality of life for patients, without negatively impacting efficacy. Results from a randomized, phase III trial of over 800 women conducted in Italy showed that lower-dose weekly carboplatin plus paclitaxel was associated … Continued

ASCO News: Kidney Cancer Drug Delays Ovarian Cancer Relapse

ASCO News: Kidney Cancer Drug Delays Ovarian Cancer Relapse

Research presented at the American Society of Clinical Oncology annual meeting this week suggests that adding the drug pazopanib (trade name Votrient) to standard treatment extends progression-free survival in ovarian cancer patients by 5.6 months. Pazopanib is an oral anti-angiogenesis drug already approved to treat kidney cancer.  The phase III study of over 900 women  … Continued

Ovarian Cancer Incidence Fell Along with Hormone Therapy Use

Ovarian Cancer Incidence Fell Along with Hormone Therapy Use

In a study published online in the Journal of Clinical Oncology on May 6, 2013, researchers reported results of a study investigating menopausal hormonal therapy (MHT) use and the incidence of ovarian cancer.  When a report from the Women’s Health Initiative linked breast cancer incidence to the use of menopausal hormonal therapy in 2002, there … Continued

Update on Treatment for Recurrent Ovarian Cancer

Update on Treatment for Recurrent Ovarian Cancer

A new article summarizes treatment options for women with recurrent ovarian cancer. The article includes information about when to treat a recurrence, what agents are available and the goals of therapy. Read the full article here

Large Study Points to Similarities Between Endometrial and ...

Large Study Points to Similarities Between Endometrial and Ovarian Cancers

According to a large new study published May 2, 2013 in the prestigious journal Nature, researchers have found that endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup, and may respond to targeted drugs already being tested in clinical trials.  Furthermore, they found that genomic alterations in uterine serous tumors—the … Continued

Experts Tackle Key Issues for Ovarian Cancer in New White P...

Experts Tackle Key Issues for Ovarian Cancer in New White Paper

Last fall, the Alliance convened a ground-breaking meeting in Washington, DC, to consider some of the most challenging topics facing the ovarian cancer community. A group of researchers, oncologists, regulatory experts, advocates and industry representatives attempted to answer questions such as: “How can more women be treated where they live?” “How can we facilitate increased … Continued

Many Ovarian Cancer Patients Use Humor to Cope

Many Ovarian Cancer Patients Use Humor to Cope

Researchers at the University of Wisconsin, including former OCRF grantee Stephen Rose, MD, conducted a qualitative research study looking at how patients with recurrent ovarian cancer experience humor to gain insight into the feasibility of using humor as a “therapeutic adjunct.” The study, which was published in the March 2013 issue of the International Journal … Continued

Report from the American Association of Cancer Researchers ...

Report from the American Association of Cancer Researchers Meeting

Ovarian cancer survivor Susan Leighton reports on her experience at the American Association of Cancer Researchers meeting, which took place in April 2013. For the second year in a row I had the privilege of being selected to attend the Scientist-Survivor Program (SSP) of the American Association of Cancer Researchers. The SSP program was established … Continued

Experimental Drug Active in Platinum-resistant Ovarian Cancer

Experimental Drug Active in Platinum-resistant Ovarian Cancer

Earlier this month at the annual meeting of the American Academy of Cancer Research, OCRF grantee Joyce Liu, MD, MPH presented research showing that 20% of women with platinum-resistant ovarian cancer responded to an experimental drug that targets a protein common in ovarian cancer. The small clinical trial is the first to show results from … Continued

Two-Step Immunotherapy Shows Promise Against Advanced Ovari...

Two-Step Immunotherapy Shows Promise Against Advanced Ovarian Cancer

In a small study presented at the annual meeting of the American Association of Cancer Research earlier this month, researchers from the University of Pennsylvania reported success with a new two-step immunotherapy approach to treating advanced ovarian cancer when combined with chemotherapy. The process begins with treatment with a personalized vaccine, which is created from … Continued

Endometriosis Treatments Lower Ovarian Cancer Risk

Endometriosis Treatments Lower Ovarian Cancer Risk

Women who had surgery to treat their endometriosis also lowered their risk of developing ovarian cancer. A study of approximately 600 Swedish women found that those who either had one ovary removed or had surgery to remove endometriotic tissue had a 20 to 42 percent lower risk of developing ovarian cancer. See the abstract here … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.